Home LiteratureArticle Details
PMID: 10516028 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Evolution of two types of rhesus lymphocryptovirus similar to type 1 and type 2 Epstein-Barr virus.

Journal of virology ·Vol. 73 ·No. 11 ·1999-11-00 ·Pages 9206-12

Cho YG, Gordadze AV, Ling PD, Wang F

Abstract

Rhesus monkeys and other nonhuman Old World primates are naturally infected with lymphocryptoviruses (LCV) that are closely related to Epstein-Barr virus (EBV). A rhesus LCV isolate (208-95) was derived from a B-cell lymphoma in a simian immunodeficiency virus-infected rhesus macaque. The EBNA-2 homologues from 208-95 and a previous rhesus LCV isolate (LCL8664) were polymorphic on immunoblotting, so the EBNA-2 genes from these two rhesus LCV were cloned, sequenced, and compared. The EBNA-2 genes have 40% nucleotide and 41% amino acid identities, and the differences are similar to those between the type 1 and type 2 EBV EBNA-2. Sequence from a portion of the LMP1 gene which is extremely divergent among different LCV was virtually identical between the 208-95 and LCL8664 strains, confirming a common rhesus LCV background. Thus, the EBNA-2 polymorphism defines the presence of two different rhesus LCV types, and both rhesus LCV types were found to be prevalent in the rhesus monkey population at the New England Regional Primate Research Center. The existence of two rhesus LCV types suggests that the selective pressure for the evolution of two LCV types is shared by human and nonhuman primate hosts.

MeSH Terms
Amino Acid Sequence Animals Base Sequence Cell Line Cloning, Molecular Epstein-Barr Virus Nuclear Antigens/chemistry,genetics Evolution, Molecular Herpesviridae Infections/veterinary,virology Humans Immunoblotting Lymphocryptovirus/classification,genetics,isolation & purification Lymphoma, B-Cell/veterinary,virology Macaca mulatta Molecular Sequence Data Monkey Diseases/virology Papio Polymorphism, Genetic Sequence Analysis, DNA Simian Acquired Immunodeficiency Syndrome/complications Tumor Virus Infections/veterinary,virology Viral Matrix Proteins/chemistry,genetics
Chemicals
EBV-associated membrane antigen, Epstein-Barr virus Epstein-Barr Virus Nuclear Antigens Viral Matrix Proteins
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Cho Y G
Department of Medicine, Brigham & Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA.
Gordadze A V
Ling P D
Wang F
References (36)
36 references, click to expand
  1. Infection of human B lymphocytes with lymphocryptoviruses related to Epstein-Barr virus.
    J Virol. 1998 Apr;72(4):3205-12 PMID: 9525646
  2. An animal model for acute and persistent Epstein-Barr virus infection.
    Science. 1997 Jun 27;276(5321):2030-3 PMID: 9197263
  3. Sequence and functional analysis of EBNA-LP and EBNA2 proteins from nonhuman primate lymphocryptoviruses.
    J Virol. 2000 Jan;74(1):379-89 PMID: 10590127
  4. Epstein-Barr virus and nonhuman primates: natural and experimental infection.
    Adv Cancer Res. 1976;23:171-201 PMID: 179290
  5. Characterization of lymphoid cell lines established from multiple Epstein-Barr virus (EBV)-induced lymphomas in a cotton-topped marmoset.
    Int J Cancer. 1977 Jul 15;20(1):44-50 PMID: 71273
  6. Herpesvirus papio DNA is similar in organization to Epstein-Barr virus DNA.
    J Virol. 1981 Feb;37(2):698-709 PMID: 6261014
  7. Colinearity between the DNAs of Epstein-Barr virus and herpesvirus papio.
    J Virol. 1981 Feb;37(2):821-6 PMID: 6261021
  8. Comparative studies of herpesvirus papio (baboon herpesvirus) DNA and Epstein-Barr virus DNA.
    J Gen Virol. 1980 Dec;51(Pt 2):245-53 PMID: 6262436
  9. U2 region of Epstein-Barr virus DNA may encode Epstein-Barr nuclear antigen 2.
    Proc Natl Acad Sci U S A. 1984 Dec;81(23):7632-6 PMID: 6209719
  10. Oropharyngeal shedding of infectious Epstein-Barr virus in healthy virus-immune donors. A prospective study.
    Chin Med J (Engl). 1985 Mar;98(3):191-6 PMID: 2988867
  11. Expression of the Epstein-Barr virus nuclear protein 2 in rodent cells.
    J Virol. 1986 Aug;59(2):453-62 PMID: 2426468
  12. Epstein-Barr virus-related herpesvirus from a rhesus monkey (Macaca mulatta) with malignant lymphoma.
    Int J Cancer. 1986 Sep 15;38(3):425-32 PMID: 3017870
  13. Geographical prevalence of two types of Epstein-Barr virus.
    Virology. 1986 Oct 15;154(1):56-66 PMID: 3019008
  14. Influence of the Epstein-Barr virus nuclear antigen EBNA 2 on the growth phenotype of virus-transformed B cells.
    J Virol. 1987 May;61(5):1310-7 PMID: 3033261
  15. Prevalence of antibodies to Epstein-Barr virus nuclear antigen 2B in persons infected with the human immunodeficiency virus.
    J Infect Dis. 1988 Jul;158(1):186-92 PMID: 2839581
  16. Distinction between Epstein-Barr virus type A (EBNA 2A) and type B (EBNA 2B) isolates extends to the EBNA 3 family of nuclear proteins.
    J Virol. 1989 Mar;63(3):1031-9 PMID: 2536817
  17. Genetic analysis of immortalizing functions of Epstein-Barr virus in human B lymphocytes.
    Nature. 1989 Aug 3;340(6232):393-7 PMID: 2547164
  18. Expression of Epstein-Barr virus nuclear antigens 3, 4, and 6 are altered in cell lines containing B-type virus.
    Virology. 1989 Aug;171(2):401-8 PMID: 2548326
  19. Detection of a second widespread strain of Epstein-Barr virus.
    Lancet. 1989 Sep 30;2(8666):761-5 PMID: 2571010
  20. Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease.
    N Engl J Med. 1989 Oct 19;321(16):1080-5 PMID: 2552313
  21. Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation.
    Proc Natl Acad Sci U S A. 1989 Dec;86(23):9558-62 PMID: 2556717
  22. Epstein-Barr virus types 1 and 2 differ in their EBNA-3A, EBNA-3B, and EBNA-3C genes.
    J Virol. 1990 Sep;64(9):4084-92 PMID: 2166806
  23. Coinfection with A- and B-type Epstein-Barr virus in human immunodeficiency virus-positive subjects.
    J Infect Dis. 1990 Sep;162(3):643-8 PMID: 2167337
  24. Epstein-Barr virus nuclear protein 2 mutations define essential domains for transformation and transactivation.
    J Virol. 1991 May;65(5):2545-54 PMID: 1850028
  25. The Epstein-Barr virus carrier state: dominance of a single growth-transforming isolate in the blood and in the oropharynx of healthy virus carriers.
    J Gen Virol. 1991 Jul;72 ( Pt 7):1579-90 PMID: 1649896
  26. A monkey model for Epstein Barr virus-associated lymphomagenesis in human acquired immunodeficiency syndrome.
    J Exp Med. 1992 Jul 1;176(1):281-6 PMID: 1319458
  27. EBNA-2 of herpesvirus papio diverges significantly from the type A and type B EBNA-2 proteins of Epstein-Barr virus but retains an efficient transactivation domain with a conserved hydrophobic motif.
    J Virol. 1993 Jun;67(6):2990-3003 PMID: 8388484
  28. Detection of multiple 'Ebnotypes' in individual Epstein-Barr virus carriers following lymphocyte transformation by virus derived from peripheral blood and oropharynx.
    J Gen Virol. 1994 Jan;75 ( Pt 1):85-94 PMID: 8113743
  29. Detection of A-type and B-type Epstein-Barr virus in throat washings and lymphocytes.
    Virology. 1994 Aug 1;202(2):978-81 PMID: 8030259
  30. Contribution of conserved amino acids in mediating the interaction between EBNA2 and CBF1/RBPJk.
    J Virol. 1995 Mar;69(3):1944-50 PMID: 7853539
  31. Epstein-Barr virus coinfection and recombination in non-human immunodeficiency virus-associated oral hairy leukoplakia.
    J Infect Dis. 1995 May;171(5):1122-30 PMID: 7751686
  32. 5' Coding and regulatory region sequence divergence with conserved function of the Epstein-Barr virus LMP2A homolog in herpesvirus papio.
    J Virol. 1995 Dec;69(12):8011-9 PMID: 7494314
  33. The N-terminal half of EBNA2, except for seven prolines, is not essential for primary B-lymphocyte growth transformation.
    J Virol. 1996 Apr;70(4):2468-73 PMID: 8642674
  34. Comparison of the EBNA1 proteins of Epstein-Barr virus and herpesvirus papio in sequence and function.
    Virology. 1996 Aug 1;222(1):1-13 PMID: 8806482
  35. Comparative analysis identifies conserved tumor necrosis factor receptor-associated factor 3 binding sites in the human and simian Epstein-Barr virus oncogene LMP1.
    J Virol. 1996 Nov;70(11):7819-26 PMID: 8892903
  36. Inhibition of antigen presentation by the glycine/alanine repeat domain is not conserved in simian homologues of Epstein-Barr virus nuclear antigen 1.
    J Virol. 1999 Sep;73(9):7381-9 PMID: 10438828
Article Info
Journal
Journal of virology
Abbr.
J Virol
ISSN
0022-538X
Published
1999-11-00
Pages
9206-12
Language
English
Region
United States
NLM ID
0113724
PMCID
PMC112954
Subset
IM
Grants
NCI NIH HHS · CA65319 · United States
NCI NIH HHS · R01 CA068051 · United States
NCRR NIH HHS · P51 RR000168 · United States
NCRR NIH HHS · P51RR00168 · United States
NCI NIH HHS · CA68051 · United States
Databases
GENBANK
AF183139, AF183140
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com